Literature DB >> 18390744

HIV envelope suppresses CD4+ T cell activation independent of T regulatory cells.

Haitao Hu1, Kathy Fernando, Houping Ni, Drew Weissman.   

Abstract

We previously demonstrated that HIV envelope glycoprotein (Env), delivered in the form of a vaccine and expressed by dendritic cells or 293T cells, could suppress Ag-stimulated CD4(+) T cell proliferation. The mechanism remains to be identified but is dependent on CD4 and independent of coreceptor binding. Recently, CD4(+) regulatory T (Treg) cells were found to inhibit protective anti-HIV CD4(+) and CD8(+) T cell responses. However, the role of Tregs in HIV remains highly controversial. HIV Env is a potent immune inhibitory molecule that interacts with host CD4(+) cells, including Treg cells. Using an in vitro model, we investigated whether Treg cells are involved in Env-induced suppression of CD4(+) T cell proliferation, and whether Env directly affects the functional activity of Treg cells. Our data shows that exposure of human CD4(+) T cells to Env neither induced a higher frequency nor a more activated phenotype of Treg cells. Depletion of CD25(+) Treg cells from PBMC did not overcome the Env-induced suppression of CD4(+) T cell proliferation, demonstrating that CD25(+)FoxP3(+) Treg cells are not involved in Env-induced suppression of CD4(+) T cell proliferation. In addition, we extend our observation that similar to Env expressed on cells, Env present on virions also suppresses CD4(+) T cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18390744     DOI: 10.4049/jimmunol.180.8.5593

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?

Authors:  Per Johan Klasse; Rogier W Sanders; Andrea Cerutti; John P Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-20       Impact factor: 2.205

2.  Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial.

Authors:  Esper G Kallas; Nicole A Grunenberg; Chenchen Yu; Bryce Manso; Giuseppe Pantaleo; Martin Casapia; Lindsey R Baden; Javier Valencia; Magdalena Sobieszczyk; Hong Van Tieu; Mary Allen; John Hural; Barney S Graham; James Kublin; Peter B Gilbert; Lawrence Corey; Paul A Goepfert; M Juliana McElrath; R Paul Johnson; Yunda Huang; Nicole Frahm
Journal:  Sci Transl Med       Date:  2019-11-20       Impact factor: 17.956

3.  Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection.

Authors:  Haitao Hu; Martin Nau; Phil Ehrenberg; Agnes-Laurence Chenine; Camila Macedo; Yu Zhou; Z John Daye; Zhi Wei; Maryanne Vahey; Nelson L Michael; Jerome H Kim; Mary Marovich; Silvia Ratto-Kim
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

4.  Engagement of the CD4 receptor affects the redistribution of Lck to the immunological synapse in primary T cells: implications for T-cell activation during human immunodeficiency virus type 1 infection.

Authors:  Alice M Nyakeriga; Carl J Fichtenbaum; Jens Goebel; Stella A Nicolaou; Laura Conforti; Claire A Chougnet
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

5.  R5-SHIV induces multiple defects in T cell function during early infection of rhesus macaques including accumulation of T reg cells in lymph nodes.

Authors:  Michael Santosuosso; Elda Righi; E David Hill; Pierre R Leblanc; Brett Kodish; Hari N Mylvaganam; Nagadenahalli B Siddappa; Liljana Stevceva; Shiu-Lok Hu; Musie Ghebremichael; Agnes-L Chenine; Avi-Hai Hovav; Ruth M Ruprecht; Mark C Poznansky
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

6.  Functional proteomic analysis for regulatory T cell surveillance of the HIV-1-infected macrophage.

Authors:  Xiuyan Huang; David K Stone; Fang Yu; Yaoying Zeng; Howard E Gendelman
Journal:  J Proteome Res       Date:  2010-11-04       Impact factor: 4.466

7.  Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion.

Authors:  Xiaohui Si; Xiaoyun Zhang; Xing Hao; Yunan Li; Zizhen Chen; Yahui Ding; Hui Shi; Jie Bai; Yingdai Gao; Tao Cheng; Feng-Chun Yang; Yuan Zhou
Journal:  Oncotarget       Date:  2016-11-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.